<DOC>
	<DOC>NCT01101087</DOC>
	<brief_summary>Dialysis catheters are sites of bacterial proliferation. The purpose of this study is to determine whether or not the use of Taurolock (a catheter lock solution) can prevent bacterial peritonitis in patients undergoing peritoneal dialysis.</brief_summary>
	<brief_title>Taurolock for Preventing Bacterial Peritonitis During Renal Insufficiency</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Peritonitis</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<criteria>18 years or older Renal insufficiency, stage V (HAS 2007 classification) Requires incident peritoneal dialysis No signs of peritoneal infection on inclusion signed consent affiliated with a social security system Patient will have a renal transplant in the upcoming year following dialysis Survival prognosis for one year is weak allergy to citrate, (cyclo)taurolidine, or heparin patient is taking medication with a known contraindication with citrate or (cyclo)taurolidine patient has a thrombopenia caused by heparin impossible to inform the patient correctly patient under guardianship patient already included in another biomedical research protocol no signed consent no social security system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Dialysis</keyword>
</DOC>